UnitedHealth Group Incorporated $UNH Shares Sold by Balboa Wealth Partners

Balboa Wealth Partners decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% in the 2nd quarter, Holdings Channel.com reports. The fund owned 811 shares of the healthcare conglomerate’s stock after selling 69 shares during the quarter. Balboa Wealth Partners’ holdings in UnitedHealth Group were worth $253,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Eos Management L.P. acquired a new stake in UnitedHealth Group during the second quarter worth $1,511,000. Swan Global Investments LLC increased its stake in UnitedHealth Group by 101.9% during the second quarter. Swan Global Investments LLC now owns 1,147 shares of the healthcare conglomerate’s stock worth $358,000 after acquiring an additional 579 shares during the last quarter. Cidel Asset Management Inc. grew its stake in shares of UnitedHealth Group by 20.7% in the second quarter. Cidel Asset Management Inc. now owns 6,511 shares of the healthcare conglomerate’s stock valued at $2,031,000 after buying an additional 1,118 shares in the last quarter. Crux Wealth Advisors grew its stake in shares of UnitedHealth Group by 10.6% in the second quarter. Crux Wealth Advisors now owns 2,002 shares of the healthcare conglomerate’s stock valued at $625,000 after buying an additional 192 shares in the last quarter. Finally, Chicago Partners Investment Group LLC grew its stake in shares of UnitedHealth Group by 26.4% in the second quarter. Chicago Partners Investment Group LLC now owns 4,606 shares of the healthcare conglomerate’s stock valued at $1,347,000 after buying an additional 962 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on UNH shares. JPMorgan Chase & Co. boosted their target price on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Jefferies Financial Group upped their target price on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research report on Friday, October 17th. Morgan Stanley upped their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Sanford C. Bernstein upped their price objective on UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research note on Wednesday, October 8th. Finally, Oppenheimer dropped their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Eighteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $385.13.

UnitedHealth Group Stock Performance

UNH opened at $365.47 on Wednesday. The stock has a market cap of $331.00 billion, a P/E ratio of 15.83, a P/E/G ratio of 2.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock’s 50 day simple moving average is $333.70 and its 200 day simple moving average is $341.28. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.